The potential of medical therapy to influence the courses and outcomes of patients with
thoracic aortic aneurysms is not known. The aim of this study was to determine whether …

Pharmacologic interventions for thoracic aneurysms remain poorly characterized. The
results of a pilot study by our group suggested improved outcomes among patients with …

Of 130 patients with abdominal aortic aneurysms (AAAs) not treated surgically, 75 (58%)
were treated with statins. The sizes of the AAAs were 4.6±0.6 cm at baseline and 4.5±0.6 cm …

The aim of this study was to evaluate the value of statins in reducing abdominal aortic
aneurysm (AAA) growth rate and improving freedom from aneurysm repair or rupture. One …

Abdominal aortic aneurysms (AAA) have a prevalence between 1.3-8.9% in men and 1.0-
2.2% in women aged above 55 years. Furthermore, AAA cause 1-3% of all deaths among …

Objective: Statins have been used widely to reduce dyslipidemia and recently have been
reported to have pleiotropic effects such as plaque reduction and stabilization. This study …

Background Pleiotropic effects of statins have been advocated for remodeling of the
vascular wall. The aim of the present study was to investigate whether statin therapy …

Background Ruptured abdominal aortic aneurysm (rAAA) is associated with high mortality.
Research suggests that statins may reduce abdominal aortic aneurysm (AAA) growth and …

PURPOSE: To assess the potential long-term beneficial effects of statin use after successful
abdominal aortic surgery. METHODS: Between 1991 and 2001, 570 patients underwent …

Background: Purpose of this study was to compare the correlation of statin use with long-
term mortality in patients with abdominal (AAA) and thoracic aortic aneurysm (TAA). Patients …